Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

September 25, 2023 7:39 (London Time)

Seelos Therapeutics

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: SEEL
Sentiment: -0.4939
MarketCap: 20,833,428.0
High: 0.19 Low: 0.15

Open: 0.18 Close: 0.16 Change: -0.02

Try an AI to get informed about investing in Seelos Therapeutics Stock.

Are looking for the most relevant information about Seelos Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Seelos Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seelos Therapeutics are: Seelos, Therapeutics, stock, Therapeutic, SEEL, trial, treatment, and the most common words in the summary are: therapeutic, stock, seelos, follow, nasdaq, top, market, . One of the sentences in the summary was: Seelos Therapeutic stock slides 58% after trial of treatment for suicidal …

Concept Map

...

Semantic Network

...

Stock Summary

Seelos Therapeutics, Inc. focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intran.

Today's Summary

Seelos Therapeutic stock slides 58% after trial of treatment for suicidal ideation has too few patients to meet endpoint - marketwatch.com. Renaissance Technologies LLC purchased a new stake in the first quarter.

Today's News

Seelos Therapeutics stock slides 58% after trial of treatment for suicidal ideation has too few patients to meet endpoint - marketwatch.com. Seelo Therapeutic Inc (SEEL) stock has gained 15.87%. Seelos Therapeutics, Inc. (seelos therapeutics, inc. (SEEL) stock price, quote, news & analysis. Seelo Therapeutic company focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. Seelos Therapeutics has a 52-week low of $0.19 on Wednesday. Renaissance Technologies LLC purchased a new stake in the first quarter valued at approximately $1,438,000. Guggenheim downgraded SeelOS Therapeutic from Buy to Neutral. Seelos Therapeutics ( NASDAQ: SEEL ) stock is down 65% in pre-market trade on Wednesday. The companys Phase 2 trial of SLS-002 did not meet its primary endpoint. Seelos Therapeutics stock price today (nasdaq: seel) quote, market cap, chart, chart | wallstreetzen. Try It for Just $1.

Stock Profile

"Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York."

Keywords

How much time have you spent trying to decide whether investing in Seelos Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seelos Therapeutics are: Seelos, Therapeutics, stock, Therapeutic, SEEL, trial, treatment, and the most common words in the summary are: therapeutic, stock, seelos, follow, nasdaq, top, market, . One of the sentences in the summary was: Seelos Therapeutic stock slides 58% after trial of treatment for suicidal ideation has too few patients to meet endpoint - marketwatch.com. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #stock #seelos #follow #nasdaq #top #market.

Read more →

Related Results

...
February 22, 2024 5:10 (London Time)

Seelos Therapeutics

Seelos Therapeutics (SEEL) is a clinical-stage biopharmaceutical company that focuses on developing novel technologies and therapeutics for the trea…
Sector: Pharmaceuticals
Ticker: SEEL
Sentiment: 0.34
MarketCap: 10,809,023.0
High: 0.82 Low: 0.76

Open: 0.78 Close: 0.8 Change: 0.02

Read more →
...
September 25, 2023 7:39 (London Time)

Seelos Therapeutics

Seelos Therapeutic stock slides 58% after trial of treatment for suicidal ideation has too few patients to meet endpoint - marketwatch.com. Renaissa…
Sector: Pharmaceuticals
Ticker: SEEL
Sentiment: -0.4939
MarketCap: 20,833,428.0
High: 0.19 Low: 0.15

Open: 0.18 Close: 0.16 Change: -0.02

Read more →
...
January 06, 2024 3:08 (London Time)

Seelos Therapeutics

Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of therapeutics to address unmet m…
Sector: Pharmaceuticals
Ticker: SEEL
Sentiment: 0.5859
MarketCap: 13,026,810.0
High: 1.37 Low: 1.3

Open: 1.32 Close: 1.34 Change: 0.02

Read more →
...
June 04, 2023 11:13 (London Time)

Seelos Therapeutics

Seelos Therapeutics Inc (SEEL) Stock Price Today, News, Quotes, FAQs and Fundamentals StockTwits Logo Join the Conversation! Build your trading netw…
Sector: Pharmaceuticals
Ticker: SEEL
Sentiment: 0.8718
MarketCap: 118,156,764.0
High: 0.99 Low: 0.92

Open: 0.99 Close: 0.94 Change: -0.05

Read more →